×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学... [136]
内容类型
期刊论文 [86]
会议论文 [50]
发表日期
2019 [19]
2018 [12]
2017 [18]
2016 [14]
2015 [18]
2014 [10]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共136条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
The outcome of patients with metastatic breast cancer with lung metastasis treated with fulvestrant is superior to that of those with liver metastasis
会议论文
作者:
He, M.
;
Li, J-J.
;
Zuo, W-J.
;
Ji, L.
;
Hu, X-C.
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/05
Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a "PET biopsy" method
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11
作者:
Zhao, Yannan
;
Wang, Biyun
;
Yang, Zhongyi
;
Li, Yi
;
Xie, Yizhao
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2019/12/05
triple-negative breast cancer
chemotherapy
PET
tumor heterogeneity
Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer
期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9
作者:
Xie, Yizhao
;
Li, Yi
;
Zhao, Yannan
;
Gong, Chengcheng
;
Hu, Xichun
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2019/12/05
Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer
期刊论文
MOLECULAR PHARMACEUTICS, 2019, 卷号: 16, 期号: 3
作者:
Sun, Yuqing
;
Li, Xuqian
;
Zhang, Lili
;
Liu, Xiao
;
Jiang, Baohong
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/12/05
TAT-NBD peptide
curcumin
celecoxib
anti-inflammation
antimetastasis
Association between insurance status at diagnosis and survival among patients with de novo metastatic breast cancer: a population-based study
会议论文
作者:
Ji, P.
;
Gong, Y.
;
Hu, X.
;
Di, G. -H.
;
Shao, Z. -M.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Prognostic value of primary tumor surgery in de novo stage IV breast cancer patients with different metastatic burdens: a propensity score-matched and weighted population-based SEER study
会议论文
作者:
Yang, Y.
;
Chen, Y.
;
Di, G.
;
Jiang, Y.
;
Shao, Z.
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2019/12/05
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
期刊论文
EUROPEAN JOURNAL OF CANCER, 2019, 卷号: 112
作者:
Yuan, Peng
;
Hu, Xichun
;
Sun, Tao
;
Li, Wei
;
Zhang, Qingyuan
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/05
Progression-free survival
Tolerability
Locally recurrent or metastatic breast cancer
Eribulin
Prognostic value of primary tumor surgery in de novo stage IV breast cancer patients with different metastatic burdens: a propensity score-matched and population-based study
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2019, 卷号: 8, 期号: 2
作者:
Jiang, Yi-Zhou
;
Shao, Zhi-Ming
;
Yang, Yun-Song
;
Chen, Ying-Le
;
Di, Gen-Hong
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2019/12/05
De novo stage IV breast cancer
surgery
propensity score matching (PSM)
inverse probability of treatment weighting (IPTW)
survival
the Surveillance
Epidemiology and End Results database (SEER)
NFATC2 suppresses the metastatic cascade in breast cancer patients
会议论文
作者:
Chi, Y.
;
Chen, J.
;
Wu, J.
;
Xue, J.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study
期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9
作者:
Xie, Yizhao
;
Zhao, Yannan
;
Gong, Chengcheng
;
Chen, Zhanhong
;
Zhang, Yinbin
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2019/12/05
©版权所有 ©2017 CSpace - Powered by
CSpace